Back to search
Adult Congenital Heart Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Adult Congenital Heart Disease trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Adult Congenital Heart Disease trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a Phase 1 study to determine the safety and efficacy of allogeneic neonatal mesenchymal stromal cells (nMSCs) for the treatment of Dilated Cardiomyopath…
The purpose of the study is to assess the safety, tolerability and the pharmacokinetics (PK) of AZD4063 after single and multiple dose administration in partici…
Background: RASopathies are a group of conditions caused by a genetic change. People with a RASopathy may have developmental issues, cognitive disability, poor…
The Congenital Heart Disease Physical Activity Lifestyle Intervention Study (CHD-PALS) V.2 seeks to determine the efficacy of a lifestyle intervention program f…
Adults with congenital heart disease (CHD) are a growing patient population in need of ongoing specialized care. Lapses in appropriate transition and transfer p…
This research study is being done to provide comparative data to the Mayo Clinic Adult Congenital Heart Disease Registry.
The primary objective of this study is to define the intracardiac flow imaging biomarkers in cardiac amyloidosis.
The purpose of this study is to compare the efficacy of Troriluzole (200 mg once daily) versus placebo after 48 weeks of treatment in subjects with spinocerebel…